OR WAIT null SECS
June 28, 2018
The companies will partner to develop T-cell therapies for cancer.
June 22, 2018
The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.
June 19, 2018
WuXi STA supported the development of hepatitis drug through marketing authorization holder pilot program.
June 13, 2018
The companies will partner in research for HIV and hepatitis B immunotherapies, and Hookipa will manufacture arenavirus-based vectors for clinical development by Gilead.
Alexion Pharmaceuticals and Complement Pharma will partner to develop a preclinical C6 complement inhibitor to treat neurodegenerative disorders.
June 07, 2018
The company will provide the first FlexFactory manufacturing platform for cell therapy manufacturing.
June 06, 2018
Under the contract, AMRI will focus on the development and manufacture of APIs and drug product for Phase I clinical studies.
May 30, 2018
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
May 25, 2018
The gene therapy company is expected to invest $55 million in a new manufacturing facility that will produce therapies for rare neurological genetic diseases.
May 23, 2018
Allergan will buy a potential depression treatment from Aptinyx.